首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   934501篇
  免费   66818篇
  国内免费   1311篇
耳鼻咽喉   13093篇
儿科学   24672篇
妇产科学   23628篇
基础医学   132924篇
口腔科学   28521篇
临床医学   80675篇
内科学   182885篇
皮肤病学   19371篇
神经病学   72093篇
特种医学   36939篇
外国民族医学   79篇
外科学   152938篇
综合类   18888篇
一般理论   242篇
预防医学   61722篇
眼科学   21409篇
药学   72687篇
  3篇
中国医学   2130篇
肿瘤学   57731篇
  2018年   8810篇
  2017年   6946篇
  2016年   7679篇
  2015年   8743篇
  2014年   11937篇
  2013年   17435篇
  2012年   24060篇
  2011年   25001篇
  2010年   14748篇
  2009年   14216篇
  2008年   24566篇
  2007年   25644篇
  2006年   26429篇
  2005年   25384篇
  2004年   24513篇
  2003年   23533篇
  2002年   23084篇
  2001年   54663篇
  2000年   56442篇
  1999年   46755篇
  1998年   10261篇
  1997年   8981篇
  1996年   9124篇
  1995年   8876篇
  1994年   8248篇
  1993年   7566篇
  1992年   35454篇
  1991年   33907篇
  1990年   32717篇
  1989年   31851篇
  1988年   28971篇
  1987年   28240篇
  1986年   26274篇
  1985年   25137篇
  1984年   17813篇
  1983年   15116篇
  1982年   7763篇
  1981年   6736篇
  1979年   15756篇
  1978年   10580篇
  1977年   9018篇
  1976年   7842篇
  1975年   8608篇
  1974年   10441篇
  1973年   9838篇
  1972年   9344篇
  1971年   8842篇
  1970年   8406篇
  1969年   7905篇
  1968年   7194篇
排序方式: 共有10000条查询结果,搜索用时 44 毫秒
1.
2.
3.
4.
5.
6.
7.
Circulating microRNAs (c-miRs) are small noncoding RNA molecules that migrate throughout the body and regulate gene expression. Global c-miR expression patterns (c-miRnomes) change with sporadic carcinogenesis and have predictive potential in early detection of cancers. However, there are no studies that have assessed whether c-miRnomes display similar potential in carriers of inherited pathogenic mismatch-repair gene variants (path_MMR), known as Lynch syndrome (LS), who are predisposed to highly increased cancer risk. Using high-throughput sequencing and bioinformatic approaches, we conducted an exploratory analysis to characterize systemic c-miRnomes of path_MMR carriers, sporadic rectal cancer patients and non-LS controls. We showed for the first time that cancer-free path_MMR carriers have a systemic c-miRnome of 40 differentially expressed c-miRs that can distinguish them from non-LS controls. The systemic c-miRnome of cancer-free path_MMR carriers also resembles the systemic c-miRnomes of cancer patients with or without path_MMR. Our pathway analysis linked the found differentially expressed c-miRs to carcinogenesis. A total of 508 putative target genes were identified for 32 out of 40 differentially expressed c-miRs, and 238 of them were enriched in cancer-related pathways. The most enriched c-miR-target genes include well-known oncogenes and tumor suppressor genes such as BCL2, AKT3, PIK3CA, KRAS, NRAS, CDKN1A and PIK3R1. Taken together, our findings suggest that LS and sporadic carcinogenesis share common biological pathways and alterations in these pathways can produce a c-miR signature which can track potential oncogenic stress in cancer-free path_MMR carriers. Therefore, c-miRs hold potential in monitoring the LS risk stratification patterns during clinical surveillance or cancer management.  相似文献   
8.
Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer mainly caused by asbestos exposure. Specific and sensitive noninvasive biomarkers may facilitate and enhance screening programs for the early detection of cancer. We investigated DNA methylation (DNAm) profiles in MPM prediagnostic blood samples in a case-control study nested in the European Prospective Investigation into Cancer and nutrition (EPIC) cohort, aiming to characterise DNAm biomarkers associated with MPM. From the EPIC cohort, we included samples from 135 participants who developed MPM during 20 years of follow-up and from 135 matched, cancer-free, controls. For the discovery phase we selected EPIC participants who developed MPM within 5 years from enrolment (n = 36) with matched controls. We identified nine differentially methylated CpGs, selected by 10-fold cross-validation and correlation analyses: cg25755428 (MRI1), cg20389709 (KLF11), cg23870316, cg13862711 (LHX6), cg06417478 (HOOK2), cg00667948, cg01879420 (AMD1), cg25317025 (RPL17) and cg06205333 (RAP1A). Receiver operating characteristic (ROC) analysis showed that the model including baseline characteristics (age, sex and PC1wbc) along with the nine MPM-related CpGs has a better predictive value for MPM occurrence than the baseline model alone, maintaining some performance also at more than 5 years before diagnosis (area under the curve [AUC] < 5 years = 0.89; AUC 5-10 years = 0.80; AUC >10 years = 0.75; baseline AUC range = 0.63-0.67). DNAm changes as noninvasive biomarkers in prediagnostic blood samples of MPM cases were investigated for the first time. Their application can improve the identification of asbestos-exposed individuals at higher MPM risk to possibly adopt more intensive monitoring for early disease identification.  相似文献   
9.
Ziling Mao  Jacqueline Roshelli Baker  Masayoshi Takeuchi  Hideyuki Hyogo  Anne Tjønneland  Anne Kirstine Eriksen  Gianluca Severi  Joseph Rothwell  Nasser Laouali  Verena Katzke  Rudolf Kaaks  Matthias B. Schulze  Domenico Palli  Sabina Sieri  Maria Santucci de Magistris  Rosario Tumino  Carlotta Sacerdote  Jeroen W. G. Derksen  Inger T. Gram  Guri Skeie  Torkjel M. Sandanger  Jose Ramón Quirós  Marta Crous-Bou  Maria-Jose Sánchez  Pilar Amiano  Sandra M. Colorado-Yohar  Marcela Guevara  Sophia Harlid  Ingegerd Johansson  Aurora Perez-Cornago  Heinz Freisling  Marc Gunter  Elisabete Weiderpass  Alicia K. Heath  Elom Aglago  Mazda Jenab  Veronika Fedirko 《International journal of cancer. Journal international du cancer》2023,152(11):2257-2268
Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for associations of circulating glycer-AGEs concentrations with CRC-specific and all-cause mortality among 1034 colorectal cancer (CRC) cases identified within the European Prospective Investigation into Cancer and Nutrition (EPIC) study between 1993 and 2013. During a mean of 48 months of follow-up, 529 participants died (409 from CRC). Glycer-AGEs were statistically significantly positively associated with CRC-specific (HRQ5 vs Q1 = 1.53, 95% CI: 1.04-2.25, Ptrend = .002) and all-cause (HRQ5 vs Q1 = 1.62, 95% CI: 1.16-2.26, Ptrend < .001) mortality among individuals with CRC. There was suggestion of a stronger association between glycer-AGEs and CRC-specific mortality among patients with distal colon cancer (per SD increment: HRproximal colon = 1.02, 95% CI: 0.74-1.42; HRdistal colon = 1.51, 95% CI: 1.20-1.91; Peffect modification = .02). The highest HR was observed among CRC cases in the highest body mass index (BMI) and glycer-AGEs category relative to lowest BMI and glycer-AGEs category for both CRC-specific (HR = 1.78, 95% CI: 1.02-3.01) and all-cause mortality (HR = 2.15, 95% CI: 1.33-3.47), although no statistically significant effect modification was observed. Our study found that prediagnostic circulating glycer-AGEs are positively associated with CRC-specific and all-cause mortality among individuals with CRC. Further investigations in other populations and stratifying by tumor location and BMI are warranted.  相似文献   
10.
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program. We performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016. We estimated the incidence rate ratio (IRR) and 95% confidence intervals (CI) for vaccination vs no vaccination by Poisson regression stratified by age at vaccination <20 years and ≥20 years. The cohort consisted of 832 732 women, of which 46 381 (5.6%) received at least one dose of HPV vaccine by the end of 2016. The incidence rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased with age regardless of vaccination status and was highest at age 25 to 29, at 637/100 000 among unvaccinated women, 487/100 000 among women vaccinated before age 20 and 831/100 000 among women vaccinated at age 20 or older. The adjusted IRR of CIN2+ between vaccinated and unvaccinated women was 0.62 (95% CI: 0.46-0.84) for women vaccinated below age 20, and 1.22 (95% CI: 1.03-1.43) for women vaccinated at age 20 or older. These findings indicate that HPV vaccination among women too old to be eligible for routine HPV vaccination is effective among women who are vaccinated below age 20 but may not have the desired impact among women who are vaccinated at age 20 or older.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号